duloxetine alembic gastroresistentne kõvakapsel
alembic pharmaceuticals europe limited - duloksetiin - gastroresistentne kõvakapsel - 40mg 28tk; 40mg 56tk; 40mg 98tk
duloxetine alembic gastroresistentne kõvakapsel
alembic pharmaceuticals europe limited - duloksetiin - gastroresistentne kõvakapsel - 30mg 28tk; 30mg 50tk; 30mg 14tk; 30mg 7tk; 30mg 98tk; 30mg 30tk
lekoklar xl 500 mg toimeainet modifitseeritult vabastav tablett
sandoz pharmaceuticals d.d. - klaritromütsiin - toimeainet modifitseeritult vabastav tablett - 500mg 7tk; 500mg 10tk; 500mg 5tk; 500mg 14tk
febuxostat alembic õhukese polümeerikattega tablett
alembic pharmaceuticals europe limited - febuksostaat - õhukese polümeerikattega tablett - 80mg 42tk; 80mg 98tk; 80mg 84tk; 80mg 28tk; 80mg 14tk
lekoklar 500 mg õhukese polümeerikattega tablett
sandoz pharmaceuticals d.d. - klaritromütsiin - õhukese polümeerikattega tablett - 500mg 14tk
bactrim siirup
eumedica pharmaceuticals gmbh - sulfametoksasool+trimetoprim - siirup - 40mg+8mg 1ml 100ml 1tk
brexin tablett
chiesi pharmaceuticals gmbh - piroksikaam - tablett - 20mg 20tk
zinforo
pfizer ireland pharmaceuticals - ceftaroline fosamil - community-acquired infections; skin diseases, infectious; pneumonia - antibacterials süsteemseks kasutamiseks, - zinforo is indicated for the treatment of the following infections in neonates, infants, children, adolescents and adults: , complicated skin and soft tissue infections (cssti), community-acquired pneumonia (cap) , consideration should be given to official guidance on the appropriate use of antibacterial agents.
xapimant suukaudne lahus
sandoz pharmaceuticals d.d. - memantiin - suukaudne lahus - 10mg 1g 100ml 1tk; 10mg 1g 50ml 1tk
xapimant õhukese polümeerikattega tablett
sandoz pharmaceuticals d.d. - memantiin - õhukese polümeerikattega tablett - 10mg 98tk; 10mg 30tk; 10mg 84tk; 10mg 7tk; 10mg 45tk; 10mg 48tk; 10mg 96tk; 10mg 20tk; 10mg 60tk; 10mg 18tk; 10mg 49tk; 10mg 100tk; 10mg 28tk; 10mg 14tk; 10mg 50tk; 10mg 42tk